Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome
NCT ID: NCT02183922
Last Updated: 2014-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2008-05-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance
NCT01215903
Intake of Omega 3 in Morbidly Obese Patients
NCT02113696
Effects of Fish Oils on Inflammation and Insulin Resistance
NCT00579436
Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
NCT00371982
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
light fruit jam
The placebo group received light fruit jam (15 g/day) during 12 weeks.
light fruit jam
The placebo group received light fruit jam (15 g/day) during 12 weeks.
microencapsulated fish oil
The microencapsulated fish oil group received light fruit jam with microencapsulated fish oil (3 g/day) during 12 weeks.
microencapsulated fish oil
The microencapsulated fish oil group received light fruit jam with microencapsulated fish oil (3 g/day) during 12 weeks.
microencapsulated conjugated linoleic acid
The microencapsulated conjugated linoleic acid group received light fruit jam with microencapsulated conjugated linoleic acid (3 g/day) during 12 weeks.
microencapsulated conjugated linoleic acid
The microencapsulated conjugated linoleic acid received light fruit jam with microencapsulated conjugated linoleic acid (3 g/day) during 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
microencapsulated conjugated linoleic acid
The microencapsulated conjugated linoleic acid received light fruit jam with microencapsulated conjugated linoleic acid (3 g/day) during 12 weeks.
microencapsulated fish oil
The microencapsulated fish oil group received light fruit jam with microencapsulated fish oil (3 g/day) during 12 weeks.
light fruit jam
The placebo group received light fruit jam (15 g/day) during 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of metabolic syndrome, as defined by the International Diabetes Federation;
* Pro12Pro genotype in gene PPARγ2.
Exclusion Criteria
* Were allergic to strawberries or fish
* Were pregnant or lactating
* Took fatty acid supplements
* Had undergone bariatric surgery or were being treated nutritionally or pharmacologically for reducing BM, or had taken anti-obesity drugs during the previous three months
30 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
OTHER_GOV
Universidade Federal do Rio de Janeiro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sofia Kimi Uehara
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sofia Uehara, Nutritionist
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Rio de Janeiro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal do Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
181/10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.